Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33591503)
Watch
English
HIV vaccines.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
HIV vaccines.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
author
Sharon E Frey
series ordinal
1
object named as
Frey SE
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
publication date
1 March 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
published in
Infectious Disease Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
volume
13
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
page(s)
95-112
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
cites work
Molecular cloning of lymphadenopathy-associated virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lessons from people with nonprogressive HIV infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and immunogenicity of a fully glycosylated recombinant gp160 human immunodeficiency virus type 1 vaccine in subjects at low risk of infection. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group Network.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials Network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic and immunologic characterization of viruses infecting MN-rgp120-vaccinated volunteers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The highest attainable standard: ethical issues in AIDS vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Pathogenic Retrovirus (HTLV-III) Linked to AIDS
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected persons
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nucleic acid immunization: a prophylactic gene therapy?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults. NIAID AIDS Vaccine Evaluation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
AIDS Research Shifts to Immunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Looking for leads in HIV's battle with immune system
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
AIDS vaccine research. A new goal: preventing disease, not infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thailand weighs AIDS vaccine tests.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV with multiple gene deletions as a live attenuated vaccine for AIDS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccine protection against simian immunodeficiency virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection of rhesus macaques from SIV infection by immunization with different experimental SIV vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Non-progression in HIV infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Persisting human immunodeficiency virus type 1 gp160-specific human T lymphocyte responses including CD8+ cytotoxic activity after receipt of envelope vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design of four-helix bundle protein as a candidate for HIV vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy trials of AIDS vaccines: how science can inform ethics.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nonhuman primate models for AIDS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and C
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The needs and hopes for an AIDS vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of immunologic responses to HIV-1MN recombinant gp160 vaccine by dose and schedule of administration. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV-1 recombinant gp160 vaccine given in accelerated dose schedules. NIAID AIDS Vaccine Clinical Trials Network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determinants of antibody response after recombinant gp160 boosting in vaccinia-naive volunteers primed with gp160-recombinant vaccinia virus. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Clinical Trials Network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The molecular biology of human immunodeficiency virus type 1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Scientific and social issues of human immunodeficiency virus vaccine development
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical, immunologic, and virologic observations related to human immunodeficiency virus (HIV) type 1 infection in a volunteer in an HIV-1 vaccine clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of a vaccine for the prevention of AIDS, a critical appraisal
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The next steps toward a global AIDS vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. WHO Network for HIV Isolation and Characterization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Shutting down HIV
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Animal models for the study of human immunodeficiency virus infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection against vaginal SIV transmission with microencapsulated vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human immunodeficiency virus type 1 infection despite prior immunization with a recombinant envelope vaccine regimen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection from HIV infection or AIDS?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
V3-specific neutralizing antibodies in sera from HIV-1 gp160-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gp120. NIH-NIAID AIDS Vaccine Clinical Tria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A formalin-inactivated whole SIV vaccine confers protection in macaques
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary human immunodeficiency virus type 1 infection: review of pathogenesis and early treatment intervention in humans and animal retrovirus infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Staging ethical AIDS trials in Africa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemokine receptors and genetic variability: another leap in HIV research
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The World Health Organization Network for HIV Isolation and Characterization: summary of a pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lymphoid organs function as major reservoirs for human immunodeficiency virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The immunopathogenesis of human immunodeficiency virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antigenic variation and serotyping of HIV type 1 from four World Health Organization-sponsored HIV vaccine sites. WHO Network for HIV Isolation and Characterization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reexamining AIDS research priorities
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety considerations for nucleic acid vaccines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A strategy for prophylactic vaccination against HIV.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alloimmunization as an AIDS vaccine?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-cell antibody in macaques
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chimpanzees in AIDS research: a biomedical and bioethical perspective.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Retroviruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunization with recombinant p17/p24:Ty virus-like particles in human immunodeficiency virus-infected persons
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of cytolytic T lymphocytes directed towards the V3 loop of the human immunodeficiency virus type 1 external glycoprotein gp120 by p55gag/V3 chimeric vaccinia viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunodeficiency viruses. 1959 and all that.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene inoculation generates immune responses against human immunodeficiency virus type 1
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Viral dynamics in human immunodeficiency virus type 1 infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HIV Type 1 Variation in World Health Organization-Sponsored Vaccine Evaluation Sites: Genetic Screening, Sequence Analysis, and Preliminary Biological Characterization of Selected Viral Strains
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feasibility of developing live attenuated HIV vaccines: conclusions and recommendations. World Health Organization Working Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vaccine protection by a triple deletion mutant of simian immunodeficiency virus.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An African HIV-1 sequence from 1959 and implications for the origin of the epidemic
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0891-5520%2805%2970045-3
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0891-5520(05)70045-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
PubMed publication ID
10198794
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10198794
retrieved
28 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
